Brief: Transgene Receives Approval From ANSM To Initiate Two Clinical Trials

Transgene SA

16/09/2019 16:50

Sept 16 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE RECEIVES APPROVAL FROM THE FRENCH HEALTH
AUTHORITY
(ANSM) TO INITIATE TWO CLINICAL TRIALS OF ITS LEAD MYVAC
INDIVIDUALIZED IMMUNOTHERAPY TG4050
    * INTERNATIONAL PHASE 1 CLINICAL TRIALS EXPECTED TO START IN
2019
    * IN FRANCE, STUDIES WILL BE CONDUCTED AT INSTITUT CURIE AND
TOULOUSE-ONCOPOLE

Source text for Eikon:  ID:nBw9HdTTTa 
Further company coverage:  TRNG.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))